Topic Archives: Biotech Millionaire

High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.

Comments

  • I would 100% Stay away from Celgene. Insider here. Their management is pretty awful and abusive to really smart people. ...

  • Is this the same Chris Wood as the Biotech Millionaire ad about an “EPIDEMIC-ENDING” DIABETES BREAKTHROUGH?...

  • Is C-V2X on the US Stock exchange? My online brokerage account can't find it....

  • Osteoarthritis is a major debilitator of older people. The only solution today is to go under the knife to have joints s...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info